Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Comment by CancerSlayeron May 21, 2023 3:41pm
353 Views
Post# 35458554

RE:Core One in Talks with Multiple Companies to Supply Psilocyb

RE:Core One in Talks with Multiple Companies to Supply Psilocyb


 

Been away from this board for a while.  I recall the old LDSYF days with Brad E. at the helm...there was a lot of reported (& even a modicum of actual) potential back then, but execution was a miserable failure for may unfortunate shareholders.  When I see words like "potential" & "could" in any announcement, I have to take a deep breath/pause...heard a lot of the same when this company was LDS.  I imagine any company in this market has that "potential".  There's no value w/o execution.  Tell me when potential is actually realized.  We all could, should & would....

From the May 5, 2023 announcement:

"The Company has the potential to produce its own psychedelic compounds at a Good Manufacturing Practices ("GMP") facility, while, in collaboration with its partners, also manufactures and could supply its high-quality and cost-effective products to licensed clients in Canada."
 

When I see words like "potential" & "could" in any announcement, I have to take a deep breath/pause...heard a lot of the same when this company was LDS.  I imagine any company in this market has "potential".  Hard to find value w/o execution of one's "potential".  Give us an NR when all of that "potential" actually becomes realized.  You can't make progress/wealth on "could, should & would..."  JMHO.

<< Previous
Bullboard Posts
Next >>